Rendon, Yvette Maris .
HRN: 27-86-16 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/12/2025
CEFUROXIME 500MG (TAB)
10/12/2025
10/18/2025
ORAL
500mg
2 Times A Day
Premature Rupture Of Membranes
Checking Final Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes